Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 565596Generated: October 30, 2026

1-Phenyl-1,3,8-triazaspiro(4.5)decan-4-one → 4-[5-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]-dec-8-ylmethyl)imidazol-1-ylmethyl]benzonitrile

https://huagongshe.com/reaction/565596

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-Phenyl-1,3,8-triazaspiro(4.5)decan-4-oneHCID 70556—
ReactantDiisopropylethylamineHCID 81531—
Reactant4-((5-(Chloromethyl)-1H-imidazol-1-yl)methyl)benzonitrile hydrochlorideHCID 9795357—
SolventAcetonitrileHCID 6342—
Product4-[5-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]-dec-8-ylmethyl)imidazol-1-ylmethyl]benzonitrileHCID 9845380—

Reaction Steps

A solution of 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (230 mg, 1 mmol), 1-(4-cyanobenzyl)-5-chloromethylimidazole hydrochloride salt (265 mg, 1 mmol), and diisopropylethylamine (0.52 mL, 3 mmol) in anhydrous acetonitrile (5 mL) was stirred at room temp. for 2 days. The resulting mixture was concentrated under vacuum, and the residue was subjected to column chromatography on silica gel eluting with 5% methanol in ethyl acetate. The appropriate fractions were collected and concentrated. The residue was triturated with diethyl ether, and the white solid precipitated was collected by filtration to provide the title compound.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06172076B2
Source datasetuspto-grants-2001_01
ORD IDord-5f90ff147f054e1f99a6d5718902709b
Source noteuspto-grants-2001_01